Drawing for EMERALD THERAPEUTICS

USPTO serial 86980181

EMERALD THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 5056365Status 710
Filing date
Status date
Registration date
Oct 4, 2016
Examiner
BAL, KAMAL SINGH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with EMERALD THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Harold Milstein

Harold Milstein Sheppard Mullin Richter & Hampton LLP1540 El Camino Real, Suite 120Menlo Park, CA 94025UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical laboratory services; scientific laboratory services; conducting laboratory experiments on behalf of others; software as a service featuring software for designing laboratory experiments, for running laboratory experiments, for reviewing laboratory experiment controls, equipment, and environment data, and for reviewing laboratory experiment results; custom assay development; research and development of chemicals, pharmaceuticals, biologics, vaccines and medical devices; scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; biopharmaceutical research design and scientific testing services; product safety testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; toxicological safety testing services for pharmaceuticals, chemicals, and consumer productsSECTION 8 - CANCELLEDJun 2, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2023C8..CANCELLED SEC. 8 (6-YR)—
Apr 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 4, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 1, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Dec 7, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 4, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 27, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 26, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 26, 2016DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 15, 2016IUAFUSE AMENDMENT FILED—
Aug 15, 2016DRRRDIVISIONAL REQUEST RECEIVED—
Aug 15, 2016ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 15, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 2, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 1, 2016EX2GSOU EXTENSION 2 GRANTED—
Mar 30, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 30, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 29, 2016EXT2SOU EXTENSION 2 FILED—
Feb 29, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 3, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 1, 2015EX1GSOU EXTENSION 1 GRANTED—
Sep 1, 2015EXT1SOU EXTENSION 1 FILED—
Sep 1, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 10, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 26, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 26, 2015COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 13, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 13, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 24, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 8, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 4, 2014ALIEASSIGNED TO LIE—
Nov 17, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 12, 2014XAECEXAMINER'S AMENDMENT ENTERED—
Nov 12, 2014GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 12, 2014GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 12, 2014CNEAEXAMINERS AMENDMENT -WRITTEN—
Nov 10, 2014DOCKASSIGNED TO EXAMINER—
Aug 5, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 31, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance